Literature DB >> 319642

The effects of oral propranolol, digoxin and combination therapy on the resting and exercise electrocardiogram.

M M LeWinter, M H Crawford, R A O'Rourke, J S Karliner.   

Abstract

The effects of propranolol, digoxin and combination therapy (/D) on the resting and exercise ECG were studied in ten normal subjects and 20 patients with coronary artery disease (CAD) given a sequence of oral placebo, propranolol, P/D, digoxin and placebo, for two week periods. Digoxin produced a significant decrease in T-wave amplitude and often resulted in ST segment depression in the resting ECG. Propranolol, digoxin, and P/D tended to decrease the QTc interval and prolong the PR interval. However, CAD patients were more sensitive to PR prolongation than normals while receiving propranolol or digoxin alone. Propranolol therapy did not significantly affect the ST segment of the exercise ECG in the normal subjects or the CAD patients without an ischemic control exercise ECG. By contrast, 50 per cent of the normal subjects developed "false-positive" ischemic ST segment responses to exercise while receiving digoxin of P/D and three of eight CAD patients without ischemic control exercise ST segments had a similar response to digoxin or P/D. In 12 CAD patients with ischemic control exercise ST segments, propranolol did not affect the amount of ST segment depression at the onset of angina or the maximum amount of ST segment depression. Digoxin or P/D both uniformly increased the maximum amount of ST segment depression which was greater with digoxin than P/D. However, the maximum heart rate on P/D was significantly reduced as compared to that on digoxin. It is concluded that (1) CAD patients are more sensitive to propranolol or digoxin-induced AV block than normals, (2) propranolol does not change the magnitude of ischemic exercise ST segment depression, (3) digoxin increases ischemic exercise ST segment depression and results in a high incidence of false-positive exercise tests, and (4) the addition of propranolol to digoxin attenuates the effects of digoxin on the exercise ST segment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 319642     DOI: 10.1016/s0002-8703(77)80312-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  The clinical importance of electrocardiographic changes during pharmacologic stress testing with radionuclide myocardial perfusion imaging.

Authors:  Elizabeth M Cosmai; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2005 Jul-Aug       Impact factor: 5.952

2.  Prognostic value of myocardial perfusion SPECT versus exercise electrocardiography in patients with ST-segment depression on resting electrocardiography.

Authors:  Andrea De Lorenzo; Rory Hachamovitch; Xingping Kang; Heidi Gransar; Maria G Sciammarella; Sean W Hayes; John D Friedman; Ishac Cohen; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

3.  Does beta adrenergic blockade influence the prognostic implications of post-myocardial infarction exercise testing?

Authors:  D P Murray; L B Tan; M Salih; P Weissberg; R G Murray; W A Littler
Journal:  Br Heart J       Date:  1988-12

4.  QT time in patients treated with alprenolol or placebo after myocardial infarction.

Authors:  G Nyberg; A Vedin; C Wilhelmsson
Journal:  Br Heart J       Date:  1979-04

5.  [Digoxin induced changes in the exercise ECG and its relation to plasma concentrations (author's transl)].

Authors:  H R Ochs; H Otten; G Bodem
Journal:  Klin Wochenschr       Date:  1979-02-15

6.  Propranolol and the respiratory, circulatory, and ECG responses to high altitude.

Authors:  U Boutellier; E A Koller
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1981

7.  Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network.

Authors:  Yubi Lin; Siqi He; Ruiling Feng; Zhe Xu; Wanqun Chen; Zifeng Huang; Yang Liu; Qianhuan Zhang; Bin Zhang; Kejian Wang; Shulin Wu
Journal:  Oncotarget       Date:  2017-06-16

Review 8.  Overview of exercise stress testing.

Authors:  Suleiman M Kharabsheh; Abdulaziz Al-Sugair; Jehad Al-Buraiki; Juman Al-Farhan
Journal:  Ann Saudi Med       Date:  2006 Jan-Feb       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.